APA (7th ed.) Citation

Chen X, Zhang D, Wang T, & Ma W. (2023). Ruxolitinib Treatment During Myelofibrosis Leads to Cutaneous Mycobacterium marinum Infection: A Case Report. Dove Medical Press.

Chicago Style (17th ed.) Citation

Chen X, Zhang D, Wang T, and Ma W. Ruxolitinib Treatment During Myelofibrosis Leads to Cutaneous Mycobacterium Marinum Infection: A Case Report. Dove Medical Press, 2023.

MLA (9th ed.) Citation

Chen X, et al. Ruxolitinib Treatment During Myelofibrosis Leads to Cutaneous Mycobacterium Marinum Infection: A Case Report. Dove Medical Press, 2023.